CTRI/2023/08/056334尚未招募4 期
A Comparative Study on Efficacy and Safety of Low Dose Oral Minoxidil Versus Oral Finasteride in the Treatment of Male Androgenetic Alopecia - nil
Rithvik Mudalakatte Hegde0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients with clinical features of Androgenetic Alopecia in the age group of 18 years to 50 years presenting in the Department of Dermatology Venerology and Leprosy, of A.J Institute of Medical Science, Mangalore.
- •2. Patients with clinical features of Androgenetic Alopecia of grades II to V according to the Norwood-Hamilton scale presenting in the Department of Dermatology Venerology and Leprosy, of A.J Institute of Medical Science, Mangalore.
- •3. Have Androgenetic Alopecia that in the opinion of the healthcare professional is suitable for treatment with both low dose oral minoxidil and oral finasteride.
排除标准
- •1. Patients who are using and/or continuing other treatment modalities for androgenetic alopecia.
- •2. Patients who have abnormal blood pressure (BP), I.e. Systolic BP < 90 or > 180 mmHg and Diastolic BP <60 or > 120 mmHg.
- •3. Patients having abnormal liver function test.
- •4. Patients having a history of abnormal thyroid conditions.
- •5. Any unstable serious co-existing medical conditions.
- •6. Patients with a history or current evidence of any serious and/or unstable pre-existing medical or psychiatric disorder.
- •7. Patients diagnosed with pheochromocytoma.
- •8. Patients having any history of heart conditions or any abnormal cardiac examination findings.
- •9. Patients with a history of allergy to oral minoxidil/finasteride or its components.
- •10. Patients with a history of use of light or laser treatment of scalp.
- •11. Patients with a history of use of minoxidil (oral/topical) within 12 months.
- •12. Patients with a history of use of Dutasteride/ finasteride within 12 months.
- •13. History of receiving chemotherapy within 12 months.
- •14. Having a scalp skin disease at the area of treatment.
- •15. Patients with a history of use of systemic steroids (i.e. prednisone, methylprednisolone, etc) for at least 2 weeks within 3 months
- •16. Patients with a history of use of drugs that will affect hair growth such as carpronium chloride, anti-androgenic drugs (cyproterone acetate, spironolactone, ketoconazole, flutamide and bicalutamide), ketoconazole shampoo, estrogen, progesterone, prostaglandin analogs, tamoxifen, drugs induced hypertrichosis (cyclosporine diazoxide, phenytoin, psoralens) drugs induced hypotrichosis/ telogen effluvium (valproic acid, anabolic steroids, lithium and phenothiazines)
- •17. Patients who are unable to give informed consent.
- •18. Non-compliant patients.
研究者
相似试验
已完成
3 期
osartan - Metoprolol XL Combination in Essential Hypertension Along with Type II DiabetesCTRI/2011/08/001937Ipca Laboratories Ltd158
Unknown
不适用
Is spinal anaesthesia more safe and effective than general anaesthesia for open surgery of gall bladder?CTRI/2015/04/005715Dr Ram Bhakta Koju120
尚未招募
不适用
A comparative study of effectiveness of Alpha2 agonist (Dexmedetomidine) versus opioid (fentanyl) for awake intubation using flexible bronchoscopeCTRI/2022/03/041196Vinayaka missions kirupanda variyar medical college and hospital
尚未招募
2 期
A clinical trial to study the effects of two drugs, metformin lotion and zinc oxide cream in patients with melasma, a type of facial pigmentatioCTRI/2023/09/057901ITHYAMS
已完成
1 期
The effect of ajicoat and cadaver on burn treatmentIRCT20190807044468N1Esfahan University of Medical Sciences50